See also this year's filing and all EDGAR filings for this company.
PDF Report 0001001316_2012_TG_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001001316, TG Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,835,667 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 629,752 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 5,441,839 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,271,056 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 7,097 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -881,974 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,907,258 |
| 1 | Liabilities | 6,271,056 |
| 2 | Expenses | 7,097 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 9,636,202 |
| 5 | NetIncome | -889,071 |
| 6 | ComprehensiveNetIncome | -889,071 |
| 7 | BaseVar | 11,533,692 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.81 |
| 9 | EconomicCapitalRatio | 2.90 |
Edgar->Model Mapping
Feature Distribution
